Sep 2, 2011 
ATEL Venture?s Portfolio Company Complete Genomics Completes IPO
ATEL Ventures Inc. announced that one of its portfolio companies, Complete Genomics, Inc. a life sciences company that develops and commercializes a DNA sequencing platform for human genome sequencing and analysis, completed its Initial Public Offering.
?Partnering with the leaders in genetic research and translational medicine gave ATEL Ventures, Inc. the opportunity to be on the ground floor from an equipment financing perspective, as this dynamic company spearheaded the development of new products to deliver high-quality, cost-effective genomic data and analysis? said Steve Rea, Executive Vice President for ATEL Ventures, Inc.
About Complete Genomics
Complete Genomics is a complete human genome sequencing company that has developed and commercialized an innovative DNA sequencing platform. The Complete Genomics Analysis Platform (CGA? Platform) combines Complete Genomics? proprietary human genome sequencing technology with our advanced informatics and data management software. They offer innovative, end-to-end, outsourced solution as CGA? Service, and provide customers with data that is immediately ready to be used for genome-based research. Additional information can be found at http://www.completegenomics.com.
ATEL Capital Group is an international financial services company that offers its clients a wide array of financial solutions including equipment leasing, asset-based lending, venture finance, lease administration and asset management. Since its inception, ATEL has sponsored thirteen public SEC-registered equipment leasing programs as well as six private growth capital investment programs. These Funds have attracted over 45,000 investors since ATEL?s first public program was created in 1986. Additional information about ATEL Capital Group can be found at www.atel.com.
us open the weather channel national weather service ashley greene weatherchannel rupert grint rupert grint
No comments:
Post a Comment